References
- Baraldo M. (2008). The influence of circadian rhythms on the kinetics of drugs in humans. Expert Opin Drug Metab Toxicol, 4, 175–92
- Becker RC, Corrao JM. (1989). Circadian variations in cardiovascular disease. Cleve Clin J Med, 56, 676–80
- Carlson DE, Chiu WC. (2008). The absence of circadian cues during recovery from sepsis modifies pituitary-adrenocortical function and impairs survival. Shock, 29, 127–32
- Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. (2005a). A review of the multiple actions of melatonin on the immune system. Endocrine, 27, 189–200
- Carrillo-Vico A, Lardone PJ, Naji L, et al. (2005b). Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J. Pineal Res, 39, 400–8
- Crespo E, Macias M, Pozo D, et al. (1999). Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J, 13, 1537–46
- Cuzzocrea S, Reiter RJ. (2002). Pharmacological actions of melatonin in acute and chronic inflammation. Curr Top Med Chem, 2, 153–65
- Cuzzocrea S, Thiemermann C, Salvemini D. (2004). Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr Med Chem, 11, 1147–62
- De Filippis D, Iuvone T, Esposito G, et al. (2008). Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress. J Pineal Res, 44, 45–51
- Drobnik J, Dabrowski R. (2000). The opposite effect of morning or afternoon application of melatonin on collagen accumulation in the sponge-induced granuloma. Neuro Endocinol Lett, 1, 195–8
- Escames G, Leon J, Macias M, et al. (2003). Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats. FASEB J, 17, 932–4
- Escames G, Acuña-Castroviejo D, López LC, et al. (2006a). Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm Pharmacol, 58, 1153–65
- Escames G, Lopez LC, Ortiz F, et al. (2006b). Age-dependent lipopolysaccharide-induced iNOS expression and multiorgan failure in rats: effects of melatonin treatment. Exp Gerontol, 41, 1165–73
- Fox K, Mulcahy D, Keegan J, Wright C. (1989). Circadian patterns of myocardial ischemia. Am Heart J, 118, 1084–6
- Gachon F, Firsov D. (2011). The role of circadian timing system on drug metabolism and detoxification. Expert Opin Drug Metab Toxicol, 7, 147–58
- Galano A, Tan DX, Reiter RJ. (2011). Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res, 51, 1–16
- Gitto E, Karbownik M, Reiter RJ, et al. (2001). Effects of melatonin treatment in septic newborns. Pediatr Res, 50, 756–60
- Gitto E, Pellegrino S, Gitto P, et al. (2009). Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res, 46, 128–39
- Gögenur I. (2010). Postoperative circadian disturbances. Dan Med Bull, 57, B4205
- Halberg F, Johnson EA, Brown BW, Bittner JJ. (1960). Susceptibility rhythm to E. coli endotoxin and bioassay. Proc Soc Exp Biol Med, 103, 142–4
- Hardeland R, Coto-Montes A, Poeggeler B. (2003). Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol Int, 20, 921–62
- Harrois A, Huet O, Duranteau J. (2009). Alterations of mitochondrial function in sepsis and critical illness. Curr Opin Anaesthesiol, 22, 143–9
- Haus E, Smolensky MH. (1999). Biologic rhythms in the immune system. Chronobiol Int, 16, 581–622
- Hrushesky WJ, Langevin T, Kim YJ, Wood PA. (1994). Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality. J Exp Med, 180, 1059–65
- Lykkesfeldt J. (2000). Determination of ascorbic acid and dehydroascorbic acid in biological samples by high-performance liquid chromatography using subtraction methods: reliable reduction with tris[2-carboxyethyl] phosphine hydrochloride. Anal Biochem, 282, 89–93
- Lykkesfeldt J. (2001). Determination of malondialdehyde as dithiobarbituric acid adduct in biological samples by HPLC with fluorescence detection: comparison with ultraviolet-visible spectrophotometry. Clin Chem, 47, 1725–7
- Lykkesfeldt J. (2007). Ascorbate and dehydroascorbic acid as reliable biomarkers of oxidative stress: analytical reproducibility and long-term stability of plasma samples subjected to acidic deproteinization. Cancer Epidemiol. Biomarkers Prev, 16, 2513–16
- Lykkesfeldt J, Loft S, Poulsen HE. (1995). Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection—are they reliable biomarkers of oxidative stress? Anal Biochem, 229, 329–35
- Marklund S. Marklund G. (1974). Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem, 47, 469–74
- Marpegan L, Leone MJ, Katz ME, et al. (2009). Diurnal variation in endotoxin-induced mortality in mice: correlation with proinflammatory factors. Chronobiol Int, 26, 1430–42
- Mauriz JL, Collado PS, Veneroso C, et al. (2013). A review of the molecular aspects of melatonin’s anti-inflammatory actions: recent insights and new perspectives. J Pineal Res, 54, 1–14
- Mundigler G, Delle-Karth G, Koreny M, et al. (2002). Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis. Crit Care Med, 30, 536–40
- Pablos MI, Reiter RJ, Ortiz GG, et al. (1998). Rhythms of glutatione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem Int, 32, 69–75
- Pincus DJ, Beam WR, Martin RJ. (1995). Chronobiology and chronotherapy of asthma. Clin Chest Med, 16, 699–713
- Reinberg AE. (1991). Concepts of circadian chronopharmacology. Ann N Y Acad Sci, 618, 102–15
- Reiter R, Swingen C, Moore L, et al. (2012). Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction. Circ Res, 110, 105–10
- Reiter RJ, Tan DX, Qi W, et al. (2000). Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Signals Recept, 9, 160–71
- Reiter RJ, Tan DX, Manchester LC, Qi W. (2001). Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys, 34, 237–56
- Sánchez-Barceló EJ, Mediavilla MD, Tan DX, Reiter RJ. (2010). Clinical uses of melatonin: evaluation of human trials. Curr Med Chem, 17, 2070–95
- Schreiber G, Tsykin A, Aldred AR, et al. (1989). The acute phase response in the rodent. Ann N Y Acad Sci, 557, 61–85
- Sewerynek E, Abe M, Reiter RJ, et al. (1995). Melatonin administration prevents lipopolysaccharide-induced oxidative damage in phrenobarbital-treated animals. J Cell Biochem, 58, 436–44
- Shang Y, Xu SP, Wu Y, et al. (2009). Melatonin reduces acute lung injury in endotoxemic rats. Chin Med J (Engl), 122, 1388–93
- Shi D, Xiao X, Wang J, et al. (2012). Melatonin suppresses proinflammatory mediators in lipopolysaccharide-stimulated CRL1999 cells via targeting MAPK, NF-kB, c/EBPB, and p300 signaling. J Pineal Res, 53, 154–65
- Srinivasan V, Pandi-Perumal SR, Spence DW, et al. (2010). Melatonin in septic shock: some recent concepts. J Crit Care, 25, 656.e1–6
- Tan DX, Manchester LC, Terron MP, et al. (2007). One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res, 42, 28–42
- Ünlü A, Türközkan N, Cimen B, et al. (2001). The Effect of Escherichia coli-derived lipopolysaccharides on plasma levels of malondialdehyde and 3-nitrotyrosine. Clin Chem Lab Med, 39, 491–3
- Wu CC, Chiao CW, Hsiao G, et al. (2001). Melatonin prevents endotoxin-induced circulatory failure in rats. J Pineal Res, 30, 147–56
- Xia MZ, Liang YL, Wang H, et al. (2012). Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells. J Pineal Res, 53, 325–34
- Zhong LY, Yang ZH, Li XR, et al. (2009). Protective effects of melatonin against the damages of neuroendocrine-immune induced by lipopolysaccharide in diabetic rats. Exp Clin Endocrinol Diabetes, 117, 463–9